Entrada Therapeutics
TRDA
TRDA
97 hedge funds and large institutions have $481M invested in Entrada Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 8 closing their positions.
Holders
97
Holders Change
+14
Holders Change %
+16.87%
% of All Funds
1.4%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
22
Increased
42
Reduced
18
Closed
8
Calls
$551K
Puts
$262K
Net Calls
+$289K
Net Calls Change
+$288K
Top Buyers
1 |
1
Janus Henderson Group
London,
United Kingdom
|
$27.4M |
2 |
2
BlackRock
New York
|
$29.1M |
3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$1.53M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$19.5M |
5 |
5
Arrowstreet Capital
Boston,
Massachusetts
|
$1.59M |